Document Detail

Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic blockade.
MedLine Citation:
PMID:  11641355     Owner:  NLM     Status:  MEDLINE    
Interleukin-6 (IL-6), an important cytokine involved in a number of biological processes, is consistently elevated during periods of stress. The mechanisms responsible for the induction of IL-6 under these conditions remain uncertain. This study examined the effect of alpha-adrenergic blockade on the IL-6 response to acute and chronic high-altitude exposure in women both at rest and during exercise. Sixteen healthy, eumenorrheic women (aged 23.2 +/- 1.4 yr) participated in the study. Subjects received either alpha-adrenergic blockade (prazosin, 3 mg/day) or a placebo in a double-blinded, randomized fashion. Subjects participated in submaximal exercise tests at sea level and on days 1 and 12 at altitude (4,300 m). Resting plasma and 24-h urine samples were collected throughout the duration of the study. At sea level, no differences were found at rest for plasma IL-6 between groups (1.5 +/- 0.2 and 1.2 +/- 0.3 pg/ml for placebo and blocked groups, respectively). On acute ascent to altitude, IL-6 levels increased significantly in both groups compared with sea-level values (57 and 84% for placebo and blocked groups, respectively). After 12 days of acclimatization, IL-6 levels remained elevated for placebo subjects; however, they returned to sea-level values in the blocked group. alpha-Adrenergic blockade significantly lowered the IL-6 response to exercise both at sea level (46%) and at altitude (42%) compared with placebo. A significant correlation (P = 0.004) between resting IL-6 and urinary norepinephrine excretion rates was found over the course of time while at altitude. In conclusion, the results indicate a role for alpha-adrenergic regulation of the IL-6 response to the stress of both short-term moderate-intensity exercise and hypoxia.
R S Mazzeo; D Donovan; M Fleshner; G E Butterfield; S Zamudio; E E Wolfel; L G Moore
Related Documents :
10648225 - Regulation of compatible solute accumulation in larvae of the mosquito culex tarsalis: ...
2085425 - Citrate anticoagulation during in vivo simulation of slow hemofiltration.
2745305 - Operation everest ii: maximal oxygen uptake at extreme altitude.
18665955 - Effect of altitude on football performance.
21537235 - Exercise and cancer survivorship.
24045635 - Echinacea purpurea supplementation does not enhance vo2max in distance runners.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  91     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-10-19     Completed Date:  2002-01-03     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2143-9     Citation Subset:  IM    
Department of Kinesiology and Applied Physiology, University of Colorado, Boulder, Colorado 80309, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic alpha-Agonists / pharmacology
Adrenergic alpha-Antagonists / pharmacology*
Anaerobic Threshold / physiology
Catecholamines / urine
Exercise / physiology*
Interleukin-6 / biosynthesis*
Menstrual Cycle / physiology
Ovary / metabolism
Oxygen Consumption / physiology
Phenylephrine / pharmacology
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Adrenergic alpha-Antagonists; 0/Catecholamines; 0/Interleukin-6; 59-42-7/Phenylephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of oxygen uptake kinetics during concentric and eccentric cycle exercise.
Next Document:  Estimating the size of the capillary-to-fiber interface in skeletal muscle: a comparison of methods.